[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"ApplicationsList":3,"BasicInfo":39,"ProductServiceList":51,"BlogDetail150Info":287},{"msg":4,"code":5,"data":6},"操作成功",0,[7,20,24,28,32,35],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":9,"title":10,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":11,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":12,"productService":8},null,9,"Oligonucleotide Drug Synthesis",90,[13,16],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":9,"orderNum":8,"ancestors":8,"id":14,"title":15,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":11,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},19,"Oligonucleotide Synthesis and Modifications",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":9,"orderNum":8,"ancestors":8,"id":17,"title":18,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":19,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},20,"Oligonucleotide biological evaluation platform",50,{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":21,"title":22,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":23,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},14,"Gene&Genome Editing",80,{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":25,"title":26,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":27,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},15,"Synthetic Biology",70,{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":29,"title":30,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":31,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},16,"Antibody Drug Discovery",60,{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":33,"title":34,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":19,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},17,"IVD Raw Material",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"parentName":8,"parentId":5,"orderNum":8,"ancestors":8,"id":36,"title":37,"excerpt":8,"content":8,"publishDate":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"productServiceId":8,"sort":38,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"applicationsSubList":8,"productService":8},18,"Vaccine and Novel Therapy",40,{"msg":4,"code":5,"data":40},{"companyName":41,"shortCompanyName":42,"title":42,"subTitle":43,"siteUrl":44,"siteDescription":45,"siteKeywords":46,"beiAnInfo":47,"email":48,"phone":49,"address":50},"GENCEFE Biotech (Wuxi, China) ","GenCefe","Your Reliable Partner of Oligo, Gene, Peptide, Protein ","https:\u002F\u002Fwww.gencefebio.com\u002F","GenCefe specializes in DNA, RNA, gene, peptide, and protein synthesis. Combined with our advanced AI-assisted design platform, we provide high-quality services for synthetic biology, molecular diagnostics, and drug discovery.","gene synthesis, oligo synthesis, RNA synthesis, DNA synthesis, peptide synthesis, protein expression and purification, gencefe, gencefe biotech","ICP备案：XXXXXXX\r\n苏公网安备32021402001785号","gene@gencefebio.com","+1 408-828-0438","17800 Castleton St, Ste 665, City of industry, CA 91748, USA",{"msg":4,"code":5,"data":52},[53,92,128,170,181,196,206,230,259,283],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":9,"title":54,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":55},"Gene Synthesis and Related Services",[56,63,68,73,78,82,87],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":57,"parentId":9,"title":58,"subTitle":59,"excerpt":60,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":61,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},11,"Gene Synthesis","Custom gene synthesis solutions with optimized design and reliable quality.","GenCefe gene synthesis services - professional technical support, free codon optimization, fast delivery and 100% accuracy guarantee.",1,"服务",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":64,"parentId":9,"title":65,"subTitle":66,"excerpt":67,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},12,"Codon Optimization","Host-specific codon optimization to support efficient recombinant protein expression.","GenCefe has introduced advanced AI technology into codon optimization and independently developed the Codon Optimization Tool, which can significantly increase the protein expression level and success rate.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":69,"parentId":9,"title":70,"subTitle":71,"excerpt":72,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},48,"Gene Fragments","Custom DNA fragments for flexible downstream assembly.","GenCefe offers DNA fragment synthesis service with strict QC standards and fast turnaround, saving time and budget for you.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":74,"parentId":9,"title":75,"subTitle":76,"excerpt":77,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},49,"Subcloning & PCR Cloning","Custom Cloning Solutions for Tailored Plasmid Construction","GenCefe Biotech can help customers clone the target gene into any site of the specified vector to meet different needs.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":19,"parentId":9,"title":79,"subTitle":80,"excerpt":81,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Plasmid Preparation","Flexible plasmid preparation tailored to your specific needs.","GenCefe provides high-quality plasmid preparation from micrograms to grams, with strict QC for batch consistency.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":83,"parentId":9,"title":84,"subTitle":85,"excerpt":86,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},51,"Mutagenesis","Custom DNA mutagenesis for precise sequence modifications.","GenCefe provides various site-directed mutagenesis services,including insertions,deletions,and substitutions,we can precisely introduce mutations into DNA sequences and deliver 100% accuracy sequences",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":88,"parentId":9,"title":89,"subTitle":90,"excerpt":91,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},52,"Gene Synthesis Case Studies","","GenCefe's experienced team has successfully delivered various difficult gene sequences, including GC-rich, repeated, ultra-long genes, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":61,"title":93,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":94},"RNAi Products & RNA Synthesis",[95,100,106,111,116,121,124],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":96,"parentId":61,"title":97,"subTitle":98,"excerpt":99,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},13,"Custom siRNA Synthesis","Custom siRNA Synthesis and Modifications for Diverse Research Needs","GenCefe provides siRNA design and custom synthesis, including standard siRNA oligos and modified siRNA oligos, to meet customers'specific needs.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":101,"parentId":61,"title":102,"subTitle":103,"excerpt":104,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":61,"newState":5,"type":105,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},22,"Pre-Designed siRNA Sets","Ready-to-Order siRNA Sets for Targeted Gene-Silencing Research","GenCefe Biotech provides 50,000+ pre-designed siRNA sets for human, rat, and mouse. Guaranteed gene silencing, free control siRNA.","产品",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":107,"parentId":61,"title":108,"subTitle":109,"excerpt":110,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},56,"Custom miRNA Mimic\u002FInhibitor","Custom miRNA Mimics and Inhibitors for In Vitro and In Vivo Research","GenCefe has developed various miRNA mimics for gain-of-function studies and inhibitors for loss-of-function studies, with different options for both in vitro and in vivo experiments.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":112,"parentId":61,"title":113,"subTitle":114,"excerpt":115,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},58,"sgRNA Synthesis","Custom gRNA Synthesis and Design with Flexible Options and Quality Control","GenCefe provides sgRNA design and chemical synthesis services. Deliverables are tested by mass spectrometry for sequence accuracy and purified by HPLC.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":117,"parentId":61,"title":118,"subTitle":119,"excerpt":120,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":61,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},59,"circRNA","Flexible circRNA Synthesis with Chemical and IVT Platforms.","GenCefe Biotech offers both chemical and IVT synthesis of circRNA, enabling customized solutions with flexible lengths and purity to meet diverse research needs.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":31,"parentId":61,"title":122,"subTitle":90,"excerpt":123,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"RNA Modifications","GenCefe Biotech provides comprehensive RNA modification, labeling, and conjugation services to meet the needs of different types of nucleic acid drug delivery.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":125,"parentId":61,"title":126,"subTitle":90,"excerpt":127,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},61,"RNA QC Standards","GenCefe Biotech is committed to providing high-quality oligonucleotide products and services; we perform HPLC detection and provide COA files for all of our oligonucleotide products by default. ",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":129,"title":130,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":131},2,"DNA Oligo Synthesis",[132,137,141,146,150,154,158,163,166],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":133,"parentId":129,"title":134,"subTitle":135,"excerpt":136,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},62,"Custom DNA Oligo Synthesis","Custom DNA Oligo Synthesis with Flexible Specifications and Reliable Quality","GenCefe provides high-quality oligonucleotide synthesis and modification services, including standard primers, qPCR primers and probes, NGS primers, etc. ",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":138,"parentId":129,"title":139,"subTitle":90,"excerpt":140,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},63,"DNA Oligo Modifications","GenCefe provides comprehensive modifications, including biotin, digoxigenin, fluorescence, phosphorylation, phosphorothioates, amino Linkers, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":142,"parentId":129,"title":143,"subTitle":144,"excerpt":145,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},64,"qPCR Primers & Probes","Custom qPCR primers and probes with flexible specifications and reliable quality.","GenCefe Biotech has established an advanced oligo synthesis and modification technology platform with an experienced technical team to provide customized qPCR primers and probes.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":147,"parentId":129,"title":148,"subTitle":90,"excerpt":149,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},65,"NGS Primers & Probes","GenCefe Biotech offers NGS adapters, blockers, capture probes, and multiplex PCR primers using advanced oligo synthesis and modification technology.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":151,"parentId":129,"title":152,"subTitle":90,"excerpt":153,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},66,"FISH Probes","GenCefe Biotech offers custom FISH probe design and synthesis with various fluorescent labels (Cy3, Cy5, FAM), HPLC purification, and expert technical support.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":155,"parentId":129,"title":156,"subTitle":90,"excerpt":157,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},67,"STR Primers"," GenCefe offers high-quality fluorescently labeled STR primers for forensic applications, with optimized dyes, purification processes, and strict quality standards.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":159,"parentId":129,"title":160,"subTitle":161,"excerpt":162,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":61,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},68,"Circular DNA","Custom single-stranded circular DNA synthesis tailored to your research needs. ","GenCefe Biotech has successfully developed single-stranded circular DNA (CssDNA) synthesis technology, providing researchers in gene expression, gene therapy, and vaccine development with a powerful new tool. ",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":27,"parentId":129,"title":164,"subTitle":90,"excerpt":165,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"PCR Assay Design and Development","GenCefe Biotech combines 10+ years oligo synthesis experience with bioinformatics and AI to offer one-step PCR assay design, synthesis, and verification services.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":167,"parentId":129,"title":168,"subTitle":90,"excerpt":169,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},71,"DNA Oligo QC","GenCefe Biotech has a strict ISO9001 & ISO13485-certified QC system for oligos, offering standard and customized QC for research and IVD applications.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":171,"title":172,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":173},3,"IVT mRNA Synthesis",[174,178],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":175,"parentId":171,"title":176,"subTitle":90,"excerpt":177,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},74,"Custom IVT mRNA Synthesis Services","GenCefe Biotech provides custom IVT mRNA synthesis services for research and therapeutic development.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":17,"parentId":171,"title":179,"subTitle":90,"excerpt":180,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":61,"newState":5,"type":105,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Off-the-shelf mRNA Products","GenCefe Biotech offers high-quality off-the-shelf products, including mRNA and circRNA, with rigorous QC for purity, activity, and stability—saving you time and costs. ",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":182,"title":183,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":184},6,"CRISPR Cas9",[185,188,192],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":186,"parentId":182,"title":113,"subTitle":90,"excerpt":187,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},34,"GenCefe Biotech provides customizable gRNA synthesis services, including sgRNA for CRISPR-Cas9 applications and pegRNA for precise genome editing and prime editing workflows.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":189,"parentId":182,"title":190,"subTitle":90,"excerpt":191,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},35,"ssDNA Synthesis Services","GenCefe Biotech offers high-purity ssDNA synthesis up to several kilobases, with minimal double-stranded DNA residues, supporting cell-based and in vivo genome editing research.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":193,"parentId":182,"title":194,"subTitle":90,"excerpt":195,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},36,"sgRNA library","CRISPR sgRNA libraries support high-throughput functional genomics screening by linking gene perturbation to phenotypic analysis for target discovery and validation.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":197,"title":198,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":199},10,"Recombinant Antibody",[200,203],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":201,"parentId":197,"title":202,"subTitle":90,"excerpt":90,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":61,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},72,"Recombinant Monoclonal Antibody Services",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":204,"parentId":197,"title":205,"subTitle":90,"excerpt":90,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},73,"Large-Scale Recombinant Antibody\u002FProtein Production",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":207,"title":208,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":209},5,"Recombinant Protein",[210,214,218,222,226],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":211,"parentId":207,"title":212,"subTitle":90,"excerpt":213,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":105,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},23,"Cell Free Expression","GenCefe offers a cell-free protein expression system for proteins that are difficult to express in conventional systems, including membrane proteins, toxic proteins, and proteins requiring non-standard amino acids.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":215,"parentId":207,"title":216,"subTitle":90,"excerpt":217,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},38,"Bacterial Expression","GenCefe provides E. coli–based protein expression services with optimization of gene design, vectors, fusion tags, and expression conditions to improve protein yield and solubility.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":219,"parentId":207,"title":220,"subTitle":90,"excerpt":221,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},53,"Mammalian Cell Expression","GenCefe’s mammalian expression systems (CHO and HEK293) produce recombinant proteins and antibodies with proper post-translational modifications for functionally relevant applications.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":223,"parentId":207,"title":224,"subTitle":90,"excerpt":225,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},54,"Insect Cell\u002FBaculovirus Expression","The insect cell\u002Fbaculovirus system enables eukaryotic protein expression with complex folding and post-translational modifications, suitable for research and development use.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":227,"parentId":207,"title":228,"subTitle":90,"excerpt":229,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},55,"Yeast Expression","Yeast-based expression systems provide a cost-effective option for recombinant protein production, supported by sequence and expression optimization strategies.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":231,"title":232,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":233},7,"Peptide Synthesis & Modification",[234,237,240,243,247,251,255],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":14,"parentId":231,"title":235,"subTitle":90,"excerpt":236,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Custom Peptide Synthesis","GenCefe Biotech uses solid- and liquid-phase peptide synthesis to deliver high-quality custom, modified, labeled, cyclized peptides, glycopeptides, and libraries.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":36,"parentId":231,"title":238,"subTitle":90,"excerpt":239,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Modified\u002FFluorescent Labeled Peptides","GenCefe provides over 300 different peptide modification groups, including: N-\u002FC-terminal modifications, fluorescent labeling, cyclic peptides, biotin labeling, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":33,"parentId":231,"title":241,"subTitle":90,"excerpt":242,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},"Stable Isotope-Labeled Peptides","GenCefe offers custom stable isotope-labeled peptides by incorporating isotope-labeled amino acids like C and N directly during synthesis, labeling the entire peptide chain.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":244,"parentId":231,"title":245,"subTitle":90,"excerpt":246,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},44,"Cyclic Peptide Synthesis","GenCefe Biotech provides clyclic peptide synthesis services, including Stapled Peptides, Cyclization at side chain, Head-to-tail cyclization, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":248,"parentId":231,"title":249,"subTitle":90,"excerpt":250,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},45,"Glycopeptides","GenCefe Biotech provides glycosylation modification services, producing glycopeptides with N-linked and O-linked types to enhance protein stability, activity, and cell signaling.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":252,"parentId":231,"title":253,"subTitle":90,"excerpt":254,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},46,"Peptide Libraries","GenCefe Biotech provides a variety of peptide library synthesis services, including over lapping libraries, random libraries, amino acid scanning libraries, etc.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":256,"parentId":231,"title":257,"subTitle":90,"excerpt":258,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":105,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},47,"Catalog Peptides","GenCefe Biotech offers over 2,000 catalog peptides covering popular research areas, available from stock.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":260,"title":261,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":262},4,"Synthetic DNA Libraries",[263,267,271,275,279],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":264,"parentId":260,"title":265,"subTitle":90,"excerpt":266,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},30,"Site-Directed Mutagenesis Libraries","Site-directed mutagenesis libraries introduce defined amino acid substitutions at selected positions, enabling structure–function studies, protein engineering, and antibody optimization.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":268,"parentId":260,"title":269,"subTitle":90,"excerpt":270,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},21,"Random Mutagenesis Libraries","Random mutagenesis libraries generate diverse sequence variants through random nucleotide mutations, making them ideal for directed evolution and functional discovery.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":272,"parentId":260,"title":273,"subTitle":90,"excerpt":274,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},31,"Degenerate (Saturation Mutagenesis) Libraries","Degenerate (saturation mutagenesis) libraries introduce NNK or NNN codons at selected positions to generate broad amino acid diversity for protein engineering and affinity maturation.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":276,"parentId":260,"title":277,"subTitle":90,"excerpt":278,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},32,"Controlled (Trimer) Libraries","Controlled (Trimer) libraries use predefined trinucleotide building blocks to precisely control amino acid diversity while reducing codon redundancy for efficient library design.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":280,"parentId":260,"title":281,"subTitle":90,"excerpt":282,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},33,"CRISPR sgRNA Libraries ","CRISPR sgRNA libraries enable high-throughput functional screening for target discovery, functional genomics, and phenotype-based studies.",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":284,"title":285,"excerpt":8,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"sort":8,"createDate":8,"secondColor":8,"showOrderPic":8,"homeState":8,"homePic":8,"homeTitle":8,"homeDesc":8,"homeSort":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"serviceFeatureList":8,"productServiceSubList":286},8,"Reagents & Kits",[],{"msg":4,"code":5,"data":288},{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":289,"categoryName":198,"title":290,"imgUrl":291,"content":292,"excerpt":90,"publishDate":293,"seoTitle":294,"seoDesc":295,"seoKeywords":296,"createDate":297,"sort":207,"relatedPostIds":298,"firstServiceProductId":197,"secondServiceProductIds":299,"relatedPost":300,"productService":356,"allSecondProductService":366,"twoSecondProductService":369},150," Recombinant Antibodies for Diagnostics: Ensuring Consistency and Lot-to-Lot Reproducibility ","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F05_20260706145917A285.png","\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F05_20260706145922A286.png\" title=\"diagnostic antibodies, assay reproducibility,\" alt=\"diagnostic antibodies, assay reproducibility,\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Diagnostic technologies rely heavily on the precision and consistency of antibodies. Whether for immunoassays, lateral-flow tests, biomarker quantification, or clinical screening, the ability of an antibody to bind reliably and reproducibly across batches is a foundational requirement. Traditional hybridoma-derived antibodies, while widely used, inherently carry biological variability that can compromise assay performance over time. Recombinant antibodies, produced through sequence-defined expression systems, have emerged as the gold standard for assays that demand long-term stability and consistency. As diagnostic markets expand and regulatory expectations increase, the advantages offered by recombinant technologies are becoming indispensable.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">The Limitations of Hybridoma-Derived Antibodies\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Hybridoma technology has contributed significantly to antibody research and product development, but its biological nature introduces unpredictability. Hybridoma cells may drift genetically or lose productivity over time, resulting in significant variation between production lots. Even subtle differences in glycosylation, sequence stability, or cell viability can translate into reduced binding affinity, altered specificity, or increased background noise in diagnostic assays. Such inconsistencies become particularly problematic in high-throughput clinical diagnostics, where precision and standardization are essential for reliable decision-making. As global regulatory frameworks tighten around assay reproducibility, reliance on unstable hybridoma lines poses increasing challenges.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">How Recombinant Antibodies Address Variability\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Recombinant antibodies overcome these limitations by anchoring production to a defined DNA sequence rather than a biologically unstable cell line. Once the sequence is identified, cloned, and validated, the antibody can be produced consistently in mammalian, bacterial, or cell-free systems with minimal variability. The expression host, culture conditions, and purification procedures can be standardized and reproduced across batches and facilities. This sequence-based control ensures that diagnostic developers receive identical molecules every time, regardless of scale or timing, eliminating the risk of genetic drift or spontaneous mutation. Such reproducibility significantly enhances product reliability and reduces batch-to-batch troubleshooting.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Stability and Long-Term Supply Assurance\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Many diagnostic assays require stable supply over multiple years, especially when incorporated into commercial diagnostic kits, regulatory submissions, or mass-market clinical tests. A single change in antibody characteristics can necessitate re-validation, leading to costly delays and compliance risks. Recombinant antibody technology directly addresses this concern by enabling unlimited production from a preserved DNA sequence stored under secure and stable conditions. This guarantees continuity of supply even if production facilities change or bioreactors are upgraded. Long-term storage of expression constructs also allows rapid scale-up, ensuring that increasing market demand does not compromise batch uniformity or timeline reliability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Enhanced Specificity Through Sequence Engineering\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Recombinant antibody platforms also provide the opportunity to refine specificity and affinity through rational sequence engineering. Developers can eliminate cross-reactivity, reduce non-specific binding, or enhance performance under specific assay conditions such as pH constraints or high-salt environments. These improvements are difficult to achieve through hybridoma methods, where antibody optimization relies on biological unpredictability. By contrast, recombinant engineering allows precise control over variable regions, constant regions, and framework stability. The result is a highly tailored molecule that performs consistently in clinical assays, even under stress or in complex matrices such as serum, plasma, or whole blood.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Regulatory Advantages and Quality Control\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">As diagnostic products face increasingly rigorous global regulatory standards, recombinant antibodies offer clear advantages in traceability, documentation, and quality assurance. Because production is sequence-defined, each batch can be validated and documented with precise molecular identity. Regulatory agencies favor such predictability, particularly in assays designed for infectious disease detection, oncology screening, and chronic disease monitoring. Consistent molecular profiles also support manufacturing audits, reduce batch-failure rates, and streamline quality control processes. For companies developing diagnostic assays intended for international markets, recombinant systems provide a robust and compliant pathway to scale.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Future Outlook: Recombinant Antibodies as the New Diagnostic Standard\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">As the diagnostic industry continues to grow, the requirement for long-term reproducibility and global standardization is becoming more critical. Recombinant antibodies are positioned to become the default option for IVD manufacturers, clinical laboratories, and biotech companies seeking dependable and scalable solutions. With advances in sequence optimization, high-throughput screening, and AI-guided antibody engineering, the next wave of diagnostic reagents will increasingly rely on recombinant production. This shift promises a more reliable and sustainable diagnostic ecosystem, enabling faster innovation and more precise clinical decision-making.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp style=\"text-wrap-mode: wrap;\">\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>","2026-01-13 00:00:00","Recombinant Antibodies for Diagnostics: Reliability, Consistency, and Lot-to-Lot Stability | GenCefe Biotech","Discover why recombinant antibodies deliver superior consistency, stability, and reproducibility in diagnostic assay development compared to hybridoma-derived antibodies.","recombinant antibodies, diagnostic antibodies, assay reproducibility, lot-to-lot consistency, antibody stability, diagnostics development, GenCefe Biotech","2026-01-13 10:39:00","154,152,149,148,146","72,73",[301,312,323,334,345],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":302,"categoryName":198,"title":303,"imgUrl":304,"content":305,"excerpt":90,"publishDate":306,"seoTitle":307,"seoDesc":308,"seoKeywords":309,"createDate":310,"sort":61,"relatedPostIds":311,"firstServiceProductId":197,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},146,"Recombinant Antibodies vs. Hybridoma Antibodies","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F10\u002F2_20260710133233A315.jpg","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F10\u002F2_20260710133233A316.jpg\" title=\"antibody expression, antibody engineering\" alt=\"antibody expression, antibody engineering\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">For decades, hybridoma technology was the cornerstone of monoclonal antibody production. Although it played an essential role in scientific development, modern research demands higher reproducibility, cleaner production processes, and more flexible antibody engineering. These needs have pushed recombinant antibodies to the forefront. The transition reflects not only technological advancement but also industry-wide expectations for precision, scalability, and complete sequence control.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Consistency and Lot-to-Lot Reproducibility\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Hybridoma-derived antibodies often suffer from genetic drift as the cell line ages. Productivity changes, mutations accumulate, and contamination risks increase. These factors make batch-to-batch consistency difficult to maintain. In contrast, recombinant antibodies are expressed from defined DNA sequences. Once the sequence is established, it remains the reference for every future production cycle. This ensures that each batch maintains identical structure, quality, and functional activity. The scientific community increasingly emphasizes reproducibility, and recombinant antibodies provide the reliability needed for long-term projects, diagnostic assay development, and regulated manufacturing environments.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Engineering Flexibility and Precision Control\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Hybridomas produce antibodies in forms constrained by the immune system, making structural refinement or functional modification difficult. Recombinant production opens the door to highly targeted engineering. Researchers can optimize antigen-binding regions to increase affinity or specificity, redesign Fc domains to modify effector functions or serum half-life, humanize sequences for therapeutic use, or reconstruct antibodies into different structural formats such as Fab, scFv, VHH, and bispecific molecules. This level of precision and freedom creates opportunities for customized solutions across basic research, diagnostics, and drug development—capabilities that traditional hybridoma systems cannot provide.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Eliminating the Limitations of Animal Immunization\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Hybridoma generation depends heavily on immunization outcomes, which vary from animal to animal. The immune response may not target the desired epitope, and the overall timeline is long and difficult to control. Additionally, hybridoma workflows carry risks of contamination and can fail if the hybridoma line becomes unstable. Recombinant antibody discovery bypasses these limitations entirely. Sequences can originate from phage display, deep B-cell sequencing, in silico design, published literature, or rational engineering of known antibodies. This simplifies the workflow, improves predictability, and reduces ethical concerns associated with animal use.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Scalability and Robust Production\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Recombinant expression systems, such as HEK293 and CHO cells, offer predictable, scalable, and well-controlled production environments. When antibody demand increases, expression can be scaled from milligram-level research quantities to gram-level preclinical or industrial volumes without changing the sequence, compromising quality, or risking cell-line instability. This scalability is critical for diagnostic manufacturers, therapeutic developers, and research groups needing consistent supply. Recombinant systems also integrate more smoothly with GMP-like processes, enabling easier transfer into clinical or production-grade facilities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Compatibility with Modern High-Throughput R&D\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Contemporary antibody research often involves parallel screening, rapid prototyping, and iterative engineering. Hybridomas are slow and require significant manual maintenance, which limits throughput. Recombinant production, however, is designed for speed and automation. Expression vectors can be rapidly constructed, and transient expression systems allow researchers to test multiple variants simultaneously. This efficiency makes recombinant antibodies ideal for next-generation sequencing-informed discovery, multi-epitope diagnostic development, and large-scale R&D programs where speed and repeatability are essential.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Applications Where Recombinant Antibodies Have Become Standard\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Recombinant antibodies have already become the norm in several critical fields. In diagnostics, the demand for high reproducibility and regulatory compliance makes defined-sequence antibodies essential. In therapeutic development, all approved monoclonal antibody drugs are recombinant because the platform allows humanization, affinity maturation, and safety engineering. In cell and gene therapy workflows, recombinant antibodies provide the purity and customization needed for vector purification, cell selection, and process monitoring. Even basic research increasingly favors recombinant formats because they reduce variability and improve data reliability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Although hybridoma technology has contributed significantly to the scientific landscape, its limitations are becoming increasingly clear in the context of modern research and industrial development. Recombinant antibodies offer unmatched consistency, engineering flexibility, scalability, and compatibility with high-throughput methodologies. As scientific standards rise and applications diversify, recombinant antibodies have become the logical and necessary evolution of antibody production.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2025-12-16 00:00:00","Recombinant vs. Hybridoma Antibodies | Advantages, Consistency & Engineering | GenCefe Biotech","Discover why recombinant antibodies outperform hybridoma antibodies in consistency, engineering flexibility, and scalability. Learn key advantages for research, diagnostics, and therapeutics.","recombinant antibodies, hybridoma antibodies, antibody production, antibody expression, antibody engineering, antibody reproducibility, diagnostic antibodies, monoclonal antibodies, antibody workflow, CHO expression, HEK293 expression","2025-12-16 14:43:29","157,156,155,154,153",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":313,"categoryName":198,"title":314,"imgUrl":315,"content":316,"excerpt":90,"publishDate":317,"seoTitle":318,"seoDesc":319,"seoKeywords":320,"createDate":321,"sort":171,"relatedPostIds":322,"firstServiceProductId":197,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},148,"Enhancing Antibody Affinity and Specificity Through VH\u002FVL Engineering","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F03_20260706145031A281.png","\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F03_20260706145037A282.png\" title=\" antibody affinity, antibody specificity\" alt=\" antibody affinity, antibody specificity\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Antibody engineering has transformed the landscape of modern biotechnology, with VH\u002FVL optimization standing at the center of efforts to improve binding affinity, target specificity, and overall molecular stability. The variable heavy (VH) and variable light (VL) domains determine how an antibody recognizes and engages its antigen. By modifying these regions through rational design, structural modeling, or directed evolution, researchers are able to enhance functional performance and expand applications across diagnostics, therapeutics, and advanced research. As recombinant antibody production becomes standard, VH\u002FVL engineering offers a powerful route to obtaining molecules that outperform their natural counterparts.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Understanding the Structural Basis of Antibody Recognition\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Antibody binding is driven primarily by the complementarity-determining regions (CDRs) within the VH and VL domains. These hypervariable loops determine the shape, charge, and hydrophobicity of the paratope, allowing the antibody to recognize specific epitopes on an antigen. The surrounding framework regions serve as the structural scaffold that stabilizes the CDRs. Even small alterations in CDR length, amino acid composition, or loop flexibility can significantly affect affinity. Similarly, adjustments to the framework can influence overall stability, expression levels, and manufacturability. Understanding the structural interplay between CDRs and frameworks is key to guiding successful engineering strategies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">CDR Optimization for Improved Affinity\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">CDR engineering is one of the most direct approaches for enhancing affinity. Modifying amino acids within CDR1, CDR2, or CDR3 can strengthen hydrogen bonding, hydrophobic interactions, or electrostatic complementarity with the antigen. For example, introducing aromatic residues can increase π-stacking interactions, while adding charged residues can improve contact with complementary surfaces. Structural modeling and computational analysis are often used to predict beneficial mutations. Experimental methods, such as targeted mutagenesis followed by high-throughput screening, further refine the design. By iterating through cycles of mutation and evaluation, antibodies with significantly improved affinity can be generated without altering their antigen specificity.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Framework Engineering for Stability and Developability\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">While CDRs drive antigen recognition, the framework regions ensure that the antibody maintains its correct fold and supports optimal CDR presentation. Engineering the frameworks can enhance thermostability, increase expression levels, reduce aggregation, and improve overall manufacturability. Substituting unstable residues or incorporating consensus framework elements can stabilize the protein. In some cases, grafting CDRs into optimized human frameworks is necessary for humanization or therapeutic development. Framework engineering also helps maintain compatibility between VH and VL domains, ensuring that the antibody assembles correctly and preserves its biological function.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Refining VH\u002FVL Pairing for Improved Binding Behavior\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">The interaction between VH and VL domains significantly influences antibody performance. Even if each domain independently binds the antigen well, their pairing can create unexpected structural constraints or alter the geometry of the binding site. Engineering efforts often examine interface residues that contribute to domain–domain packing. Rational modifications can promote favorable hydrophobic interactions or strengthen hydrogen-bond networks at the interface. Improving VH\u002FVL pairing frequently results in enhanced affinity, greater expression efficiency, and increased antibody stability. In some cases, altering the orientation of the domains can reveal novel binding configurations or broaden epitope recognition.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Applying Computational Tools to Predict High-Performance Designs\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Advances in molecular modeling, AI-based structure prediction, and energy-scoring algorithms have significantly accelerated VH\u002FVL engineering. Computational methods can analyze structural conformations, predict mutation impacts, and identify optimized CDR loop geometries. These tools help narrow down large mutation libraries and prioritize variants with high predicted stability or improved binding energy. Structural databases and machine-learning models trained on antibody–antigen complexes further assist in designing variants that maintain specificity while enhancing affinity. By integrating computation with experimental validation, researchers can reduce development time and increase design success.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Directed Evolution to Discover High-Affinity Variants\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">In addition to rational design, directed evolution offers a powerful way to improve antibody affinity by mimicking natural selection. Libraries of VH or VL variants are generated through random mutagenesis or targeted diversification approaches. These libraries are expressed in display systems such as phage, yeast, or mammalian display, where they undergo multiple rounds of antigen binding selection. Variants with the strongest interactions are enriched and further refined. Directed evolution can identify unexpected beneficial mutations that computational analysis might overlook, making it a valuable complement to structure-based engineering.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat;\">Balancing Affinity With Developability Requirements\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Although high affinity is often a desired outcome, it is important to ensure that engineered antibodies retain favorable developability properties. Excessively high affinity may reduce dissociation rates, impair epitope accessibility, or interfere with biological mechanisms such as receptor turnover. VH\u002FVL engineering therefore requires careful optimization to balance affinity, specificity, stability, and expression levels. Developability assessments—including aggregation propensity, charge distribution analysis, and thermostability evaluation—ensure that high-affinity antibodies also perform well in manufacturing and downstream applications.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">VH\u002FVL engineering enables the creation of antibodies with optimized affinity, enhanced specificity, and improved structural stability. Through CDR modification, framework optimization, interface engineering, computational modeling, and directed evolution, researchers can reshape antibody properties with remarkable precision. As recombinant antibody technologies advance, VH\u002FVL engineering has become a central strategy in developing next-generation diagnostic antibodies, therapeutic candidates, and research tools capable of meeting increasingly demanding performance standards.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; color: rgb(79, 129, 189);\">,\u003C\u002Fspan>\u003Cspan style=\"font-family: Montserrat;\"> as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2025-12-30 00:00:00","VH\u002FVL Engineering for Antibody Optimization | Affinity & Specificity Improvement | GenCefe Biotech","Discover how VH\u002FVL engineering improves antibody affinity and specificity. Learn key strategies such as CDR optimization, framework engineering, and structural refinement for high-performance recombinant antibodies.","VH VL engineering, antibody affinity, antibody specificity, CDR optimization, antibody engineering, recombinant antibody design, affinity maturation, antibody structure, therapeutic antibody optimization","2025-12-30 13:17:15","155,153,152,151,149",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":324,"categoryName":198,"title":325,"imgUrl":326,"content":327,"excerpt":90,"publishDate":328,"seoTitle":329,"seoDesc":330,"seoKeywords":331,"createDate":332,"sort":260,"relatedPostIds":333,"firstServiceProductId":197,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},149,"Fc Engineering: Applications and Trends in Antibody Drug Development","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F04_20260706145835A283.png","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F04_20260706145840A284.png\" title=\"antibody drug development\" alt=\"antibody drug development\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Fc engineering has become an essential pillar in the evolution of antibody therapeutics. As antibody drugs mature beyond simple target binding, the Fc region—once considered merely a structural backbone—has emerged as a powerful design element capable of modulating immune response, pharmacokinetics, tissue distribution, and overall therapeutic behavior. Modern biologics rely not only on the antigen-binding domain but also on the refined functions of the Fc region to achieve enhanced efficacy and safety. As the biopharmaceutical industry moves toward next-generation antibody formats, Fc engineering is reshaping how antibodies are optimized for oncology, autoimmune diseases, infectious diseases, and beyond.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Understanding the Role of the Fc Region\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The Fc region is responsible for mediating interactions between antibodies and various immune components, including Fcγ receptors, complement proteins, and neonatal Fc receptors (FcRn). These interactions determine whether an antibody primarily triggers cytotoxic immune responses, enhances phagocytosis, or prolongs its presence in circulation. Because each therapeutic antibody may require a specific balance between effector functions and half-life, manipulating the Fc region has become an indispensable strategy for designing precisely tuned biologics.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">In oncology, for example, strong effector functions such as antibody-dependent cellular cytotoxicity (ADCC) or complement-dependent cytotoxicity (CDC) are desirable. In contrast, for inflammatory or autoimmune diseases, the optimal therapeutic effect often requires minimizing immune activation to avoid exacerbating disease progression. Understanding these functional contexts is foundational for selecting an Fc engineering strategy.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Enhancing Effector Functions for Targeted Cytotoxicity\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">One of the most widely adopted uses of Fc engineering is enhancing the antibody’s ability to recruit immune cells to eliminate pathogenic targets. By altering Fcγ receptor binding affinities through amino acid substitutions or glyco-engineering, developers can significantly increase ADCC and CDC potency.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">An important example is the optimization of Fc glycan structures. Removing fucose residues (afucosylation) can dramatically improve an antibody’s interaction with FcγRIIIa receptors, resulting in stronger NK-cell–mediated cytotoxic responses. This approach has led to the development of several clinically approved antibodies demonstrating higher tumor-killing efficiency compared with their non-engineered counterparts.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">These engineered enhancements have expanded the potential of monoclonal antibodies in cancer immunotherapy, allowing more precise and powerful targeting of tumor cells without increasing systemic toxicity.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Suppressing Immune Activation for Autoimmune and Chronic Diseases\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">While strengthening immune activation is valuable in oncology, certain therapeutic areas require the opposite outcome. For autoimmune diseases, chronic inflammation, or enzyme replacement therapy, it’s often necessary to reduce effector functions to prevent unintended tissue damage.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">To address this requirement, Fc silencing mutations have been developed to diminish binding to Fcγ receptors and eliminate complement recruitment. By eliminating these interactions, engineered antibodies retain target affinity but minimize immune-mediated side effects. These modifications have directly contributed to the improved tolerability and safety of biologics targeting inflammatory pathways, making them suitable for long-term treatment regimens.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Improving Pharmacokinetics Through FcRn Optimization\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Beyond immune effector regulation, Fc engineering is a powerful method for modulating antibody half-life. Through interactions with FcRn receptors, antibodies can be recycled instead of being degraded, allowing them to remain in circulation for weeks. Consequently, introducing engineered mutations that enhance FcRn binding at acidic pH is a proven way to prolong half-life and reduce dosing frequency.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Such modifications have set new standards for patient compliance by enabling monthly or even quarterly dosing intervals for chronic conditions. As more therapeutics aim for self-administration and long-acting formulations, FcRn-enhancing mutations are becoming increasingly prevalent in drug development pipelines.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Fc Engineering in Emerging Antibody Formats\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Fc engineering is now integrated into many advanced therapeutic platforms, including bispecific antibodies, antibody–drug conjugates (ADCs), and therapeutic fusion proteins. In bispecific formats, Fc modifications help stabilize the molecule, balance arm pairing, and fine-tune immune activation. For ADCs, an optimized Fc region ensures better pharmacokinetics and more reliable trafficking to target tissues.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">With the advancement of AI-assisted protein design and high-throughput screening, Fc engineering is also evolving toward more predictive, data-driven strategies. Machine learning models are increasingly used to identify mutation combinations that enhance stability or modulate immune interactions, accelerating development timelines and increasing success rates.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Future Trends in Fc Engineering\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Research continues to push the boundaries of what the Fc region can achieve. Novel directions include Fc variants designed to localize antibodies to specific tissues, Fc switches that respond to physiological cues, and immune-modulating designs that create more selective or context-dependent effector functions. These emerging technologies reflect a broader shift toward highly customizable antibody platforms, where each functional aspect can be tuned to meet the needs of precision medicine.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">As regulatory agencies and industry stakeholders gain more experience with engineered Fc designs, the adoption of these innovations is expected to accelerate, shaping the next generation of safer, more effective, and more versatile therapeutic antibodies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>","2026-01-06 00:00:00","Fc Engineering in Antibody Drug Development: Mechanisms, Applications, and Future Trends | GenCefe Biotech","Learn how Fc engineering enhances antibody efficacy, stability, and therapeutic performance, and explore current technologies and trends shaping next-generation antibody therapeutics.","Fc engineering, antibody drug development, Fc region modification, ADCC, CDC, half-life extension, recombinant antibodies, GenCefe Biotech","2026-01-06 14:53:05","156,155,154,152,147",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":335,"categoryName":198,"title":336,"imgUrl":337,"content":338,"excerpt":90,"publishDate":339,"seoTitle":340,"seoDesc":341,"seoKeywords":342,"createDate":343,"sort":231,"relatedPostIds":344,"firstServiceProductId":197,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},152,"Optimizing Antibody Yield and Stability in Recombinant Production","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F07_20260706150020A289.png","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F07_20260706150026A290.png\" title=\"antibody stability, codon optimization\" alt=\"antibody stability, codon optimization\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Recombinant antibody production is a complex process influenced by genetic design, host cell characteristics, culture conditions, and downstream processing. Achieving high yield and long-term stability is critical for research applications, diagnostic assays, and therapeutic development. Optimizing these parameters ensures not only efficient production but also reproducible performance across batches. With careful design and systematic workflow, recombinant antibodies can meet stringent quality requirements while maintaining structural integrity and functional activity.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Codon Optimization and Gene Design\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The DNA sequence encoding an antibody greatly impacts expression efficiency. Codon usage differs across species, and mismatched codons can slow translation and reduce protein yield. By performing codon optimization for the chosen expression host—whether HEK293, CHO, or other mammalian systems—translation efficiency is maximized. Additionally, sequence engineering can reduce mRNA secondary structures, eliminate cryptic splice sites, and remove repetitive motifs that may hinder expression. Careful gene design thus lays the foundation for both high yield and functional stability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Selection of Expression Host and Culture Conditions\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The choice of host cells is a key determinant of antibody production and stability. HEK293 cells are often preferred for rapid, small-scale research production due to high transfection efficiency and fast expression. CHO cells, in contrast, provide robust growth, high-density culture capability, and consistent protein glycosylation, making them ideal for preclinical and commercial-scale production. Optimizing culture conditions—such as media composition, temperature shifts, feeding strategies, and bioreactor parameters—can further enhance yield and promote proper protein folding, reducing aggregation and misfolding.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Protein Folding and Quality Control\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Proper folding is essential for antibody activity and stability. Misfolded proteins can aggregate or lose binding specificity, compromising both research results and therapeutic applications. Mammalian expression systems provide essential post-translational modifications, disulfide bond formation, and chaperone-assisted folding. Monitoring folding efficiency through analytical techniques such as size-exclusion chromatography, SDS-PAGE, and mass spectrometry ensures that only correctly folded antibodies proceed to purification, preserving functional activity and reducing batch variability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Purification Strategies for Stability\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Downstream purification is another critical factor affecting antibody stability. Affinity chromatography, particularly Protein A\u002FG capture, enables high-purity recovery while maintaining native conformation. Polishing steps such as ion-exchange and size-exclusion chromatography remove aggregates, host-cell proteins, and residual nucleic acids. Formulation choices—including pH, buffer composition, and stabilizing excipients—further enhance long-term stability, ensuring antibodies remain active during storage and shipment.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Enhancing Thermal and Storage Stability\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Thermal stability directly affects both shelf life and functional performance. Introducing stabilizing mutations, optimizing buffer conditions, and controlling storage temperature are common strategies to extend stability. Lyophilization or inclusion of cryoprotectants can further preserve antibody structure, particularly for long-term storage or transport under variable conditions. These measures are especially important for diagnostic reagents, research antibodies shipped internationally, and therapeutic candidates that require extended shelf life.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Scaling Up Without Compromising Quality\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Scale-up introduces new challenges in yield and stability. Maintaining consistent culture conditions, minimizing shear stress in bioreactors, and carefully monitoring bioprocess parameters are essential for large-scale production. Recombinant antibody platforms allow predictable scale-up because the underlying gene sequence is constant and expression conditions are well-characterized. This reproducibility ensures that antibodies retain activity and stability across different production scales, from milliliters to liters.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Optimizing recombinant antibody yield and stability requires an integrated approach spanning gene design, host selection, culture optimization, protein folding, purification, and formulation. By carefully managing these parameters, researchers and developers can produce antibodies that are both high-yielding and structurally robust, supporting applications in research, diagnostics, and therapeutics. Recombinant production platforms provide the necessary control and flexibility to achieve these goals efficiently.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2026-01-27 00:00:00","Optimizing Recombinant Antibody Yield and Stability: Strategies for High-Quality Production | GenCefe Biotech","Learn key strategies to optimize yield and stability of recombinant antibodies, including codon optimization, host selection, culture conditions, and purification techniques.","recombinant antibody yield, antibody stability, codon optimization, expression host selection, mammalian expression, protein folding, GenCefe Biotech","2026-01-27 15:44:24","154,153,151,150,149",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":346,"categoryName":198,"title":347,"imgUrl":348,"content":349,"excerpt":90,"publishDate":350,"seoTitle":351,"seoDesc":352,"seoKeywords":353,"createDate":354,"sort":9,"relatedPostIds":355,"firstServiceProductId":197,"secondServiceProductIds":299,"relatedPost":8,"productService":8,"allSecondProductService":8,"twoSecondProductService":8},154,"Bispecific Antibodies: Design Strategies and Therapeutic Applications","http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F09_20260706150130A293.jpg","\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2026\u002F07\u002F06\u002F09_20260706150136A294.jpg\" title=\" antibody engineering, dual-target therapeutics,\" alt=\" antibody engineering, dual-target therapeutics,\" width=\"100%\"\u002F>\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Bispecific antibodies (bsAbs) represent a rapidly growing class of next-generation therapeutics capable of simultaneously engaging two distinct antigens or epitopes. This dual-targeting capability offers unprecedented flexibility for modulating complex biological pathways, redirecting immune cells toward tumor cells, or enhancing specificity in inflammatory diseases. The development of bispecific antibodies requires sophisticated engineering to ensure correct chain pairing, maintain structural stability, and preserve biological activity. As clinical applications expand, understanding the design principles and potential therapeutic benefits of bsAbs is essential for researchers and developers.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Design Strategies for Bispecific Antibodies\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Designing a bispecific antibody involves several key challenges, primarily ensuring correct heavy-light chain pairing and maintaining structural integrity. Multiple formats have been developed to address these challenges, including tandem single-chain variable fragments (scFv), dual-variable domain antibodies, and IgG-like bispecifics with engineered Fc regions. Each format has unique advantages in terms of stability, half-life, effector function, and manufacturability.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Molecular engineering often focuses on optimizing domain interfaces, introducing mutations that favor correct pairing, and minimizing misfolded or aggregated species. Advanced computational modeling and high-throughput screening are commonly used to predict and validate structural compatibility, enabling the generation of functionally active bispecific molecules.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Functional Advantages of Dual-Targeting\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Bispecific antibodies offer functional advantages that conventional monospecific antibodies cannot achieve. In oncology, one arm can engage a tumor-associated antigen while the other recruits immune effector cells such as T cells or NK cells. This approach enables precise immune redirection, enhancing tumor cell killing while minimizing off-target toxicity. In autoimmune or inflammatory diseases, bispecifics can simultaneously block two signaling pathways, providing synergistic therapeutic effects that are difficult to achieve with separate antibodies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The dual-targeting mechanism also allows for fine-tuning of immune responses and improved therapeutic windows, reducing side effects and potentially enabling lower dosing regimens. This versatility has led to a surge of clinical trials exploring bispecific antibodies across a range of diseases.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Engineering Challenges and Solutions\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Despite their promise, bispecific antibodies pose several engineering challenges. Correct chain pairing is critical to prevent misassembled products, and maintaining stability can be difficult due to increased structural complexity. Glycosylation, solubility, and aggregation are additional factors that must be carefully controlled.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Several strategies address these challenges. Knobs-into-holes mutations in Fc regions improve heterodimer formation, while domain swapping and charge-pair engineering ensure correct heavy-light chain interactions. Glycoengineering and expression optimization further enhance stability and solubility. By integrating these approaches, developers can produce bispecific antibodies with high yield, functional potency, and long-term stability suitable for clinical use.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Clinical Applications of Bispecific Antibodies\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Bispecific antibodies are particularly prominent in cancer immunotherapy. Molecules that engage CD3 on T cells and a tumor antigen can directly recruit cytotoxic T cells to tumor cells, enabling potent anti-tumor activity. Other applications include targeting immune checkpoints, inflammatory mediators, or infectious pathogens.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Beyond oncology, bispecific antibodies are explored for autoimmune disease, viral neutralization, and regenerative medicine. The ability to simultaneously modulate two biological targets offers therapeutic strategies that are otherwise difficult to achieve with conventional monoclonal antibodies or combination therapies.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Future Trends and Perspectives\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">The future of bispecific antibodies is driven by improved molecular design, AI-assisted modeling, and novel expression platforms. Researchers are exploring multispecific formats, conditional bispecifics, and modular designs that can adapt to dynamic therapeutic needs. As production technologies advance, scalable and cost-effective manufacturing solutions are becoming more feasible, accelerating clinical development and commercialization. Bispecific antibodies are set to play a central role in the next generation of precision therapeutics, offering unprecedented versatility and efficacy.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">recombinant antibody and protein production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">. Supported by our well-established \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F9-Gene_Synthesis_and_Related_Services.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">gene synthesis\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\"> platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"text-decoration: underline; font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">\u003Cspan style=\"font-family: Montserrat; font-size: 16px; color: rgb(79, 129, 189);\">antibody and protein purification\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","2026-02-10 00:00:00","Bispecific Antibodies: Engineering Strategies, Functional Advantages, and Clinical Applications | GenCefe Biotech","Explore the design strategies and therapeutic applications of bispecific antibodies, including formats, engineering challenges, and their potential in oncology and immunotherapy.","bispecific antibodies, antibody engineering, dual-target therapeutics, recombinant antibodies, antibody formats, immunotherapy, GenCefe Biotech","2026-02-10 14:20:01","152,151,150,149,148",{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":197,"title":198,"excerpt":90,"content":357,"seoTitle":358,"seoDesc":359,"seoKeywords":360,"sort":227,"createDate":361,"secondColor":362,"showOrderPic":5,"homeState":61,"homePic":363,"homeTitle":198,"homeDesc":364,"homeSort":31,"orderDesc":90,"orderUrl":365,"email":48,"phone":49,"onlineFormUrl":365,"serviceFeatureList":8,"productServiceSubList":8},"\u003Cp>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">Led by an experienced team of recombinant antibody and protein scientists, GenCefe Biotech provides comprehensive solutions for \u003C\u002Fspan>\u003Ca href=\"https:\u002F\u002Fwww.gencefebio.com\u002FproductsAndservices\u002F10-Recombinant_Antibody.html\" style=\"font-family: Montserrat; text-decoration: underline;\">\u003Cspan style=\"font-family: Montserrat;\">recombinant antibody production\u003C\u002Fspan>\u003C\u002Fa>\u003Cspan style=\"font-family: Montserrat;\"> and protein production. Supported by our well-established gene synthesis platform and advanced CHO and HEK293 mammalian expression systems, we deliver end-to-end services—from gene synthesis and expression vector construction to antibody and protein purification, as well as large-scale manufacturing.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\"> \u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"font-family: Montserrat;\">We offer efficient, stable, and customizable antibody expression solutions for academic institutions and biopharmaceutical companies, enabling smooth transitions from fundamental research to drug development. With our robust technical systems and extensive project experience, GenCefe is committed to accelerating antibody R&D and enhancing translational efficiency for innovative discoveries.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">GenCefe Recombinant Antibody & Protein Solution\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp>\u003Cstrong>\u003Cspan style=\"font-family: Montserrat; font-size: 16px;\">\u003Cimg src=\"http:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2025\u002F11\u002F20\u002F图片3_20251120164845A006.png\" title=\"\" alt=\"\"\u002F>\u003C\u002Fspan>\u003C\u002Fstrong>\u003C\u002Fp>\u003Cp style=\"text-align:center\">\u003Cbr\u002F>\u003C\u002Fp>\u003Cp>\u003Cbr\u002F>\u003C\u002Fp>","Recombinant Antibody | Fast Turnaround from 1 Week-GenCefe","GenCefe provides recombinant antibody expression and purification for antibody development, therapeutic research, antigen binding studies, and immunoassays.","Recombinant Antibody Expression, Recombinant Monoclonal Antibody Expression, Recombinant mAb Production, Custom Recombinant Antibody, Antibody Expression Services","2025-11-20 09:55:49","#185192","https:\u002F\u002Fmanage.gencefebio.com\u002Fprofile\u002Fupload\u002F2025\u002F11\u002F24\u002F抗体-蓝_20251124160642A001.png","Delivering fast, high-quality recombinant antibody solutions.","https:\u002F\u002Fforms.zohopublic.com\u002Fgencefebiotech1\u002Fform\u002FRecombinantAntibodyQuoteForm\u002Fformperma\u002FuJSYaxh8gmZuKHDp5D3hdXdkonkzBZ6lhYmlygYkmP8",[367,368],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":201,"parentId":197,"title":202,"subTitle":90,"excerpt":90,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":61,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":204,"parentId":197,"title":205,"subTitle":90,"excerpt":90,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},[370,371],{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":201,"parentId":197,"title":202,"subTitle":90,"excerpt":90,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":61,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8},{"createBy":8,"createTime":8,"updateBy":8,"updateTime":8,"remark":8,"id":204,"parentId":197,"title":205,"subTitle":90,"excerpt":90,"content":8,"seoTitle":8,"seoDesc":8,"seoKeywords":8,"createDate":8,"orderDesc":8,"orderUrl":8,"email":8,"phone":8,"onlineFormUrl":8,"sort":8,"hotState":5,"newState":5,"type":62,"customerTestimonials":8,"productCatalog":8,"relatedTitles":8,"productService":8,"customerTestimonialsList":8,"relatedTitlesList":8,"serviceFeatureSubList":8,"productCatalogList":8}]